Aim Pelvic exenteration surgery remains the only curative option for recurrent rectal cancer. Microscopically involved surgical margins (R1) are associated with a higher risk of local recurrence and decreased survival. Our study aimed to develop a post hoc multidisciplinary case conference review and investigate its potential for identifying areas for improvement. Method Results Patients who underwent pelvic exenteration surgery for recurrent rectal cancer with R1 resections at a tertiary referral centre between April 2014 and January 2016 were retrospectively reviewed from a prospectively maintained database. Patients with non-rectal cancers or who underwent palliative surgery were excluded. Cases, imaging and histopathology were evaluated...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
International audienceOBJECTIVE: Pelvic exenteration requires complete resection of the tumor with n...
Objective: To examine the changes in exenterative surgery over three decades analysing oncological o...
Aim Pelvic exenteration surgery remains the only curative option for recurrent rectal cancer. Micros...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...
Introduction: Currently in the UK, 11-14000 patients are diagnosed with rectal cancer each year sixt...
SummaryBackgroundThe role of pelvic exenteration in locally advanced rectal cancer (LARC) has not be...
AbstractBackgroundThe incidence of rectal cancer recurrence after surgery is 5–45%. Extended pelvic ...
BACKGROUND: Over one-third of primary rectal cancers are locally advanced at diagnosis, and local re...
Background: The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been cl...
INTRODUCTION: Rectal cancer is the third most commonly diagnosed cancer occurring in both males and...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
International audienceOBJECTIVE: Pelvic exenteration requires complete resection of the tumor with n...
Objective: To examine the changes in exenterative surgery over three decades analysing oncological o...
Aim Pelvic exenteration surgery remains the only curative option for recurrent rectal cancer. Micros...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
Background Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent recta...
Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cance...
Background: Despite multimodal therapy 5–15% of patients who undergo resection for advanced rectal...
Introduction: Currently in the UK, 11-14000 patients are diagnosed with rectal cancer each year sixt...
SummaryBackgroundThe role of pelvic exenteration in locally advanced rectal cancer (LARC) has not be...
AbstractBackgroundThe incidence of rectal cancer recurrence after surgery is 5–45%. Extended pelvic ...
BACKGROUND: Over one-third of primary rectal cancers are locally advanced at diagnosis, and local re...
Background: The role of pelvic exenteration in locally advanced rectal cancer (LARC) has not been cl...
INTRODUCTION: Rectal cancer is the third most commonly diagnosed cancer occurring in both males and...
Background: Pelvic exenteration for locally recurrent rectal cancer (LRRC) is associated with variab...
Objective: The aim of the study was to analyze data from an international collaboration, and ascerta...
International audienceOBJECTIVE: Pelvic exenteration requires complete resection of the tumor with n...
Objective: To examine the changes in exenterative surgery over three decades analysing oncological o...